Tickerplace logo

Tickerplace

bioAffinity Technologies, Inc. logo

BIAFbioAffinity Technologies, Inc.

BIAF Stock Price, Valuation & Chart | bioAffinity Technologies, Inc.

Compare
$3.730-0.23 (-5.81%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Diagnostics & Research
OverviewFinancialsDividendsRatios

BIAF Historical price chart

BIAF Key Stats

Market Capitalization23.44M
PE Ratio-0.44
EPS-8.52
Trading Volume100.10K
Today's High/Low3.95/3.63
Dividend Yield0.00
52 Week High/Low80.7/3.23
Shares Outstanding6.28M
BIAF Financial Statement
BIAF Analyst ratings
BIAF Analysis & performance metrics

BIAF Company profile

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung,…

BIAF Management team

Management
Timothy P. Zannes J.D.
Executive Vice President, Secretary & General Counsel
Steven Girgenti
Founder & Executive Chairman of the Board
Julie Anne OvertonCTO
Director of Communications
William Bauta Ph.D.
Chief Science Officer
Maria Zannes J.D.CEO
Founder, President, Chief Executive Officer & Director
James Michael Edwards CPA, M.B.A.CFO
Chief Financial Officer & Principal Accounting Officer
Dallas J. Coleman
Vice President of sales
Xavier T. Reveles M.S.COO
Chief Operating Officer
Total 8 executives

BIAF Frequently asked questions

What is bioAffinity Technologies, Inc. (BIAF) Stock Price?

Current stock price of bioAffinity Technologies, Inc. (BIAF) stock is $3.730. The stock price is -5.81% lower in the session. The intraday range can be seen from this page. Volume of bioAffinity Technologies, Inc. (BIAF) stock is 100.10K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the bioAffinity Technologies, Inc. (BIAF) stock price going up or down today?

The stock price of bioAffinity Technologies, Inc. (BIAF) can change with earnings, company news, and overall market sentiment. bioAffinity Technologies, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the bioAffinity Technologies, Inc. stock expensive at its current price?

Whether bioAffinity Technologies, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BIAF on this page is -0.44. EPS on this page is -8.52. Compare those figures with peers and growth expectations before deciding if the current bioAffinity Technologies, Inc. price is justified.

How has the stock price of bioAffinity Technologies, Inc. (BIAF) performed historically?

Historical performance for bioAffinity Technologies, Inc. (BIAF) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BIAF reacted to past earnings and market events.

Should I buy bioAffinity Technologies, Inc. (BIAF) stock, at this price?

Buying bioAffinity Technologies, Inc. (BIAF) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.